Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Preferred Stock Liabilities: 2015

  • Syndax Pharmaceuticals' Preferred Stock Liabilities was N/A to $319.1 million in Q4 2015 from the same period last year, while for Dec 2015 it was $319.1 million, marking a year-over-year change of. This contributed to the annual value of $319.1 million for FY2015, which is N/A change from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported Preferred Stock Liabilities of $319.1 million as of Q4 2015.
  • In the past 5 years, Syndax Pharmaceuticals' Preferred Stock Liabilities registered a high of $319.1 million during Q4 2015, and its lowest value of $319.1 million during Q4 2015.
  • In the last 1 years, Syndax Pharmaceuticals' Preferred Stock Liabilities had a median value of $319.1 million in 2015 and averaged $319.1 million.